"Today, the U.S. Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.
Latisse Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Latisse (bimatoprost) Ophthalmic Solution is a synthetic prostaglandin analog used to treat patients with not enough or inadequate eyelashes. It is also used to treat glaucoma. Common side effects include eye redness/discomfort/itching/dryness or eyelid redness.
Once nightly, place a one drop dose of Latisse 0.03% on the disposable sterile applicator supplied with the package and apply evenly along the skin of the upper eyelid margin at the base of the eyelashes. Blot excess solution runoff outside the upper eyelid margin with a tissue or absorbent cloth. Dispose of the applicator after one use. Repeat for the opposite eyelid margin using a new sterile applicator. Latisse may interact with glaucoma eye drops (such as bimatoprost, latanoprost, travoprost). Tell your doctor all medications and supplements you use. During pregnancy, Latisse should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Latisse (bimatoprost) Ophthalmic Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Latisse Overview - Patient Information: Side Effects
It is possible for hair growth to happen in other areas of your skin where this medication frequently touches. Be sure to wipe any extra medication after applying it to the eyelash margins (see also How to Use section).
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
It has been shown that when this medication is applied directly into the eyes to treat glaucoma, it may slowly (over months to years) cause brown discoloration of the colored portion of the eye (iris). This effect has not been shown to occur when this medication is used to improve eyelash appearance. However, bimatoprost may also cause eyelid changes or a darkening of the skin around the base of the eyelashes. These changes may be permanent, but the long-term effects are uncertain. Tell your doctor if this occurs.
Tell your doctor immediately if any of these unlikely but serious side effects occur: eye pain, suspected eye infection (discharge, unusual redness, swelling of eyes), rapid vision changes (such as loss of vision).
A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Latisse (Bimatoprost Ophthalmic Solution 0.03% for Hypotrichosis)»
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Latisse FDA Prescribing Information: Side Effects
Clinical Studies Experience
The following information is based on clinical trial results from a multicenter, double-masked, randomized, vehicle-controlled, parallel study including 278 adult patients for four months of treatment.
The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. These events occurred in less than 4% of patients.
Adverse reactions reported with bimatoprost ophthalmic solution (LUMIGAN®) for the reduction of intraocular pressure include, ocular dryness, visual disturbance, ocular burning, foreign body sensation, eye pain, blepharitis, cataract, superficial punctate keratitis, eye discharge, tearing, photophobia, allergic conjunctivitis, asthenopia, increases in iris pigmentation, conjunctival edema, abnormal hair growth, iritis, infections (primarily colds and upper respiratory tract infections), headaches, and asthenia.
The following reactions have been identified during postmarketing use of LATISSE® in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting possible causal connection to LATISSE®, or a combination of these factors, include: burning sensation (eyelid), eye swelling, eyelid irritation, eyelid edema, eyelids pruritus, iris hyperpigmentation, lacrimation increased, madarosis and trichorrhexis (temporary loss of a few lashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), periorbital and lid changes associated with a deepening of the eyelid sulcus, rash (including macular, erythematous, and pruritic limited to the eyelids and periorbital region), skin discoloration (periorbital), and vision blurred.
Read the entire FDA prescribing information for Latisse (Bimatoprost Ophthalmic Solution 0.03% for Hypotrichosis) »
Additional Latisse Information
Latisse - User Reviews
Latisse User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Skin & Beauty
Get beauty tips and body treatments.